Going It Alone: Eli Lilly CEO John Lechleiter has become the holdout kid. Unlike his chief rivals, he vows the 134-year-old drugmaker will strike no mega-deals as its top medicines face a seeming Apocalypse of patent expirations, Reuters reports.
Where's Leo: The hottest new game at the Oracle Corp.-SAP AG infringement trial has become “Where in the World is Leo Apotheker?” Oracle lawyers want to put the former SAP chief executive officer on the stand in federal court in Oakland, Calif., Bloomberg reports.
Spelling Counts: Alaska state officials said Tuesday they plan to proceed with this week’s count of write-in ballots in the Senate contest after Republican Joe Miller sued the state’s lieutenant governor and Division of Elections in federal court to try stop the state’s plan for counting write-in ballots that misspell the name of his rival Sen. Lisa Murkowski, The Wall Street Journal reports.
Antitrust Down Under: Australia's competition watchdog questioned on Wednesday whether Singapore Exchange's $8.2 billion takeover bid for Australia's ASX Ltd could stall the entry of competing trading platforms into the country, Reuters reports.
Klein Resigns: Joel I. Klein, who presided over a radical reorganization of the New York City school system resigned on Tuesday as chancellor after eight years in the job, The New York Times reports. He previously served as head of the Justice Department’s Antitrust Division.